Transcriptomics

Dataset Information

0

A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients With Locally Advanced or Metastatic Cancers


ABSTRACT: Gene sets enriched in tumor tissue in response to dosing with ivuxolimab from eight paired biopsies of patients dosed with ≥ 1.5 mg/kg indicated that gene sets associated with immune activation and inflammation were among those most enriched (higher positive normalized enrichment score [NES]) with the lowest adjusted P values.

ORGANISM(S): Homo sapiens

PROVIDER: GSE184752 | GEO | 2021/11/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2010-01-11 | GSE17794 | GEO
2010-06-30 | E-GEOD-3625 | biostudies-arrayexpress
| PRJNA766060 | ENA
2024-10-31 | GSE205576 | GEO
2024-10-31 | GSE205575 | GEO
2024-10-31 | GSE205573 | GEO
2022-01-25 | GSE117042 | GEO
2021-02-20 | GSE147108 | GEO
2024-10-31 | GSE205577 | GEO
2021-05-01 | GSE173622 | GEO